--- title: Explore our Services | Halloran Consulting Group description: Halloran's regulatory team expertly guides programs to marketing applications (NDAs, BLAs, PMAs, 510(k)s), ensuring success in late-stage development. --- ![hcg-service-hero-1](https://hallorancg.com/hs-fs/hubfs/2024%20Halloran%20Site/Global/hcg-service-hero-1.webp?width=300&name=hcg-service-hero-1.webp) # Marketing Applications     - [SERVICES](https://hallorancg.com/services?hsLang=en) - [CLINICAL DEVELOPMENT PHASE](https://hallorancg.com/services/clinical-development?hsLang=en) - [MARKETING APPLICATIONS](https://hallorancg.com/services/clinical-development/marketing-applications) ## PREPARING REGULATORY MARKETING APPLICATIONS **Bringing innovative healthcare solutions to market is a multifaceted journey, and our services offer a strategic roadmap tailored to various application types, resulting in projects firmly grounded in a clear pathway to market success. At Halloran, our regulatory team navigates programs through to marketing applications (NDAs, BLAs, PMAs, 510(k)s), providing guidance on critical late-stage development programs to ensure success. Whether acting as advisors, authors, or any role in between, we are committed to facilitating your journey to market authorization. This is the heart of our vision to enable life science innovation together and to improve human health around the world.** Our comprehensive suite of services encompasses a diverse range of application types, each meticulously designed to pave the way for market authorization: - 510(k) Application: Guiding you through the 510(k) application process for medical devices, ensuring market access while meeting regulatory standards - BLA (Biologics License Application): Assisting in preparing and submitting BLAs for biopharmaceutical products, ensuring compliance with regulatory requirements for market authorization - MAA (Marketing Authorization Application): Helping prepare MAA submissions for European Medicines Agency (EMA) approval, facilitating market entry in the European Union - NDA (New Drug Application): Providing NDA preparation and submission services, ensuring your new drug meets regulatory standards for market authorization - PMA (Pre-Market Approval): Guiding you through the PMA process for medical devices, ensuring compliance with FDA requirements for market entry ### CLINICAL DEVELOPMENT SERVICES - [Investigational New Drug (IND) Application](https://hallorancg.com/services/pre-clinical/investigational-new-drug-application?hsLang=en) - [Clinical Trial Leadership & Operations](https://hallorancg.com/services/clinical-development/clinical-trial-leadership-operations?hsLang=en) - [CRO Selection & Qualification](https://hallorancg.com/services/clinical-development/cro-selection-qualification?hsLang=en) - [Medical Writing](https://hallorancg.com/services/pre-clinical/medical-writing?hsLang=en) - [GxP Quality Assessment & Remediation](https://hallorancg.com/services/clinical-development/gpx-quality-assessment-remediation?hsLang=en) - [GxP Data Integrity](https://hallorancg.com/services/clinical-development/gxp-data-integrity?hsLang=en) - [Lifecycle Support](https://hallorancg.com/services/clinical-development/lifecycle-support?hsLang=en) - **[Marketing Applications](https://hallorancg.com/services/clinical-development/marketing-applications?hsLang=en)** - [Inspection Readiness](https://hallorancg.com/services/clinical-development/inspection-readiness?hsLang=en) - [Regulatory Operations](https://hallorancg.com/services/clinical-development/regulatory-operations?hsLang=en) - [Clinical Role-Based Engagements](https://hallorancg.com/services/clinical-development/clinical-role-based-engagements?hsLang=en) The journey to market a new drug or biologic culminates in the submission of an NDA or BLA to the FDA, representing the final step in obtaining permission to market a new pharmaceutical product. This critical phase requires robust scientific data, comprehensive clinical findings, and meticulous documentation to demonstrate the safety, efficacy, and quality of the therapy. Partnering with Halloran for your NDA/BLA submission process offers numerous benefits: - Regulatory Insight: Direct access to regulatory experts with years of FDA experience, providing valuable insights into current FDA hot topics - Strategic Foresight: Proactive identification of potential hurdles and implementation of strategies to mitigate risks - Efficient Outcomes: Streamlined processes that save time and resources while maximizing the likelihood of approval Through our structured and strategic approach, we have achieved a high success rate in first-cycle approvals by the FDA, earning recognition for comprehensive and well-structured submission documents. Our long-term collaborations with clients reflect our reliability and expertise, making us a trusted partner in navigating the complex landscape of regulatory submissions. CLINICAL DEVELOPMENT ## RELATED SERVICES [![hcg-service-image-box-background](https://9483922.fs1.hubspotusercontent-na1.net/hub/9483922/hubfs/2024%20Halloran%20Site/Global/hcg-service-image-box-background.webp?width=300&name=hcg-service-image-box-background.webp) INVESTIGATIONAL NEW DRUG (IND) APPLICATION INVESTIGATIONAL NEW DRUG (IND) APPLICATIONRead More ](https://hallorancg.com/services/preclinical/investigational-new-drug-application?hsLang=en)[![hcg-service-image-box-background](https://9483922.fs1.hubspotusercontent-na1.net/hub/9483922/hubfs/2024%20Halloran%20Site/Global/hcg-service-image-box-background.webp?width=300&name=hcg-service-image-box-background.webp) CLINICAL TRIAL LEADERSHIP & OPERATIONS CLINICAL TRIAL LEADERSHIP & OPERATIONSRead More ](https://hallorancg.com/services/clinical-development/clinical-trial-leadership-operations?hsLang=en)[![hcg-service-image-box-background](https://9483922.fs1.hubspotusercontent-na1.net/hub/9483922/hubfs/2024%20Halloran%20Site/Global/hcg-service-image-box-background.webp?width=300&name=hcg-service-image-box-background.webp) CRO SELECTION & QUALIFICATION CRO SELECTION & QUALIFICATIONRead More ](https://hallorancg.com/services/clinical-development/cro-selection-qualification?hsLang=en)[![medical writing](https://9483922.fs1.hubspotusercontent-na1.net/hub/9483922/hubfs/2024%20Halloran%20Site/Global/hcg-service-image-box-background.webp?width=300&name=hcg-service-image-box-background.webp) MEDICAL WRITING MEDICAL WRITINGRead More ](https://hallorancg.com/services/preclinical/medical-writing?hsLang=en)[![hcg-service-image-box-background](https://9483922.fs1.hubspotusercontent-na1.net/hub/9483922/hubfs/2024%20Halloran%20Site/Global/hcg-service-image-box-background.webp?width=300&name=hcg-service-image-box-background.webp) GPX QUALITY ASSESSMENT & REMEDIATION GPX QUALITY ASSESSMENT & REMEDIATIONRead More ](https://hallorancg.com/services/clinical-development/gxp-quality-assessment-remediation?hsLang=en)[![GXP DATA INTEGRITY](https://9483922.fs1.hubspotusercontent-na1.net/hub/9483922/hubfs/2024%20Halloran%20Site/Global/hcg-service-image-box-background.webp?width=300&name=hcg-service-image-box-background.webp) GXP DATA INTEGRITY GXP DATA INTEGRITYRead More ](https://hallorancg.com/services/clinical-development/gxp-data-integrity?hsLang=en)[![hcg-service-image-box-background](https://9483922.fs1.hubspotusercontent-na1.net/hub/9483922/hubfs/2024%20Halloran%20Site/Global/hcg-service-image-box-background.webp?width=300&name=hcg-service-image-box-background.webp) LIFECYCLE SUPPORT LIFECYCLE SUPPORTRead More ](https://hallorancg.com/services/clinical-development/lifecycle-support?hsLang=en)[![hcg-service-image-box-background](https://9483922.fs1.hubspotusercontent-na1.net/hub/9483922/hubfs/2024%20Halloran%20Site/Global/hcg-service-image-box-background.webp?width=300&name=hcg-service-image-box-background.webp) INSPECTION READINESS INSPECTION READINESSRead More ](https://hallorancg.com/services/clinical-development/inspection-readiness?hsLang=en)[![hcg-service-image-box-background](https://9483922.fs1.hubspotusercontent-na1.net/hub/9483922/hubfs/2024%20Halloran%20Site/Global/hcg-service-image-box-background.webp?width=300&name=hcg-service-image-box-background.webp) REGULATORY OPERATIONS REGULATORY OPERATIONSRead More ](https://hallorancg.com/services/clinical-development/regulatory-operations?hsLang=en)[![hcg-service-image-box-background](https://9483922.fs1.hubspotusercontent-na1.net/hub/9483922/hubfs/2024%20Halloran%20Site/Global/hcg-service-image-box-background.webp?width=300&name=hcg-service-image-box-background.webp) CLINICAL ROLE-BASED ENGAGEMENTS CLINICAL ROLE-BASED ENGAGEMENTSRead More ](https://hallorancg.com/services/clinical-development/clinical-role-based-engagements?hsLang=en) ![hcg-form-microscope-background-2](https://hallorancg.com/hs-fs/hubfs/2024%20Halloran%20Site/Global/hcg-form-microscope-background-1.webp?width=300&name=hcg-form-microscope-background-1.webp) REACH YOUR MILESTONES ## LET’S GET TO WORK Halloran has the team and the experience to help you in your lifecycle journey. Contact us today to learn more about how we can help you! STAY UP-TO-DATE ## LATEST INSIGHTS [VIEW ALL INSIGHTS](https://hallorancg.com/insights?hsLang=en) [ Elizabeth Bodi ### How to Operationalize AI Governance in Clinical Trials Start Reading ](https://hallorancg.com/insights/how-to-operationalize-ai-governance-in-clinical-trials?hsLang=en)[ Carolina Ahrendt, MBA, PMP ### Insights from Biocom’s 2026 Global Life Science Partnering & Investor Conference Start Reading ](https://hallorancg.com/insights/-insights-from-biocoms-2026-global-life-science-partnering-investor-conference?hsLang=en)[ Monika Swietlicka, MBA, BFA, BSc ### The Angstrom Game: How Biotech Turns Biology into Investable Assets Start Reading ](https://hallorancg.com/insights/the-angstrom-game-how-biotech-turns-biology-into-investable-assets?hsLang=en) ```json { "@context" : "https://schema.org", "@type" : "Organization", "address" : { "@type" : "PostalAddress", "addressCountry" : "", "addressLocality" : "Cambridge", "addressRegion" : "MA", "postalCode" : "02142", "streetAddress" : "245 Main Street" }, "knowsLanguage" : "en", "logo" : { "@type" : "ImageObject", "url" : "https://9483922.fs1.hubspotusercontent-na1.net/hubfs/9483922/Orange%20Tree%20Blue%20Text.png" }, "name" : "Halloran Consulting Group, a PLG Company", "url" : "https://hallorancg.com/services/clinical-development/marketing-applications" } ```